Quaternised renzapride as a potent and selective 5-HT4 receptor agonist
- 1 April 1993
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 3 (4) , 633-634
- https://doi.org/10.1016/s0960-894x(01)81243-9
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- SC-53116: the first selective agonist at the newly identified serotonin 5-HT4 receptor subtypeJournal of Medicinal Chemistry, 1992
- Benzimidazolone derivatives act as 5-HT4 receptor ligands in rat oesophagusEuropean Journal of Pharmacology, 1992
- Peristalsis evoked by 5‐HT and renzapride: evidence for putative 5‐HT4 receptor activationBritish Journal of Pharmacology, 1991
- Azabicycloalkyl benzimidazolones: Interaction with serotonergic 5-HT3 and 5-HT4 receptors and potential therapeutic implicationsDrugs of the Future, 1991
- Piglet sinoatrial 5-HT receptors resemble human atrial 5-HT4-like receptorsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1990
- Synthesis of a new class of 2,3-dihydro-2-oxo-1H-benzimidazole-1-carboxylic acid derivatives as highly potent 5-HT3 receptor antagonistsJournal of Medicinal Chemistry, 1990
- The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neuronsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1989
- [3H]-BRL 43694 (granisetron), a specific ligand for 5-HT3 binding sites in rat brain cortical membranesBiochemical Pharmacology, 1989
- Increased gut cholinergic activity and antagonism of 5‐hydroxytryptamine M‐receptors by BRL 24924: potential clinical importance of BRL 24924British Journal of Pharmacology, 1987
- Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugsNature, 1985